Covered recipient · General Payments record
OMAR BARI
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$2,414.17
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $725.01 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $178.22 | 5 |
| Janssen Biotech, Inc. | $146.91 | 1 |
| Incyte Corporation | $145.99 | 2 |
| Arcutis Biotherapeutics, Inc. | $134.64 | 1 |
| UCB, Inc. | $102.21 | 1 |
| Lilly USA, LLC | $17.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | $134.64 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121067557 | CMS |
| E.R. Squibb & Sons, L.L.C. | $109.73 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702692 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.38 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702714 | CMS |
| E.R. Squibb & Sons, L.L.C. | $11.37 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702732 | CMS |
| E.R. Squibb & Sons, L.L.C. | $38.00 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702743 | CMS |
| E.R. Squibb & Sons, L.L.C. | $4.74 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702769 | CMS |
| Incyte Corporation | $5.99 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141289890 | CMS |
| Incyte Corporation | $140.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141315153 | CMS |
| Janssen Biotech, Inc. | $146.91 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078528347 | CMS |
| Lilly USA, LLC | $17.04 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135181882 | CMS |
| UCB, Inc. | $102.21 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143063277 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.